Back

Peri-ablation semaglutide exposure and atrial fibrillation recurrence: a meta-analysis of time-to-event outcomes

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation ablation: insights from systematic reviews and meta-analyses Rhythm Control, Catheter Ablation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ali Abdulrazzaq

Brookdale University Hospital & Medical Center, Brooklyn (United States of America)

5 More presentations in this session

Presentation thumbnail
Impact of Glucagon-like peptide-1 receptor agonists on atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis
Doctor E. Rodriguez (Chicago, US)
Abstract Slides Video
Presentation thumbnail
Glp-1 receptor agonists as adjunctive therapy to catheter ablation in atrial fibrillation: a systematic review and meta-analysis
Doctor S. Deaconu (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Oral anticoagulation after catheter ablation: does continuation or discontinuation affect major cardiovascular outcomes? a systematic review and meta-analysis of 143,855 patients
Mr M. Ramirez Benavides (Lima, PE)
Abstract Slides Video
Presentation thumbnail
Contemporary pulsed field ablation systems for atrial fibrillation: a systematic review and network meta-analysis
Doctor A. Leow (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Impact of continuous positive airway pressure therapy for obstructive sleep apnea on atrial fibrillation recurrence following catheter ablation: a comprehensive systematic review and meta-analysis
Doctor R. Khan (IN) Doctor H. Ramteke (Chimur, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation ablation: insights from systematic reviews and meta-analyses

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparing GLP-1 agonists versus other weight loss interventions on atrial fibrillation recurrence after catheter ablation: a meta-regression analysis
31 March 2025
thumbnail
Congress Presentation
Empagliflozin to prevent post-operative atrial fibrillation in patients undergoing coronary artery bypass graft surgery (EMPOAF), a randomized, double-blind, placebo-controlled trial
28 August 2026
thumbnail
Congress Presentation
Catheter ablation as first versus second-line therapy for atrial fibrillation: a frequentist and bayesian meta-analysis with reconstructed time-to-event and trial sequential analysis
14 April 2026
thumbnail
Congress Presentation
SGLT2 inhibitors and the risk of atrial fibrillation recurrence within one year after radiofrequency ablation
13 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources